needle-free alternative

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nasus Pharma CEO to Present Pipeline at Three Major Healthcare Conferences

Nasus Pharma CEO presents clinical pipeline at three major healthcare conferences in February-March, showcasing NS002 intranasal epinephrine for anaphylaxis treatment.
NSRXclinical-stageinvestor conference